Diligence memo · auto-generated · as of July 2, 2026

MetaModix, Inc.

MetaModix, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

MetaModix, Inc. operates in Other Health Care, based in PLYMOUTH.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

MetaModix, Inc. has raised $7.6M in disclosed capital across 11 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.9M on 2011-07-01.

Most recent recorded round closed around 2023-01-13.

Valuation (modeled)modeled

Provath models MetaModix, Inc. at approximately $4.2M (range $423K–$16M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.35× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 12 months.

Last raise 3.5 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 5.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 71% of Other Health Care peers (5377 compared).

Modeled value ranks above 18% of those peers.

Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.